Thematic area:
Novel Sensors
Product:
Biocompatible biosensors integrated into mechanical circulatory support devices (e.g., LVADs) to capture real-time hemodynamic data such as rhythm, flow, pressure – improving safety and reducing readmissions.
Market:
Designed for the expanding heart failure and LVAD market. Total addressable market is estimated at ~€190M across the US/EU, with opportunities for partnerships with major cardiovascular device companies.
Fit:
Addresses a critical gap: a lack of real-time physiological monitoring in LVAD patients. Improves clinical decision-making, reduces complications, and aligns well with future MCSD innovation trends.
